Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
164.00
+1.00 (0.61%)
At close: Jan 21, 2026
142.96% (1Y)
| Market Cap | 254.20B |
| Revenue (ttm) | 34.99M |
| Net Income (ttm) | -488.25M |
| Shares Out | 1.55B |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | 68.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9,236,149 |
| Average Volume | 5,956,318 |
| Open | 163.00 |
| Previous Close | 163.00 |
| Day's Range | 156.00 - 165.00 |
| 52-Week Range | 54.10 - 277.00 |
| Beta | 0.68 |
| RSI | 57.04 |
| Earnings Date | Feb 6, 2026 |